Neal Bhatia, MD

George Han, MD, PhD, guides a discussion on the mechanism of action of TNF-alpha inhibitors used to treat plaque psoriasis.

Key opinion leaders in the management of plaque psoriasis review factors to consider regarding quality of life when treating patients with topical agents, phototherapy, and biologics.

Panelists discuss the importance of assessing disease severity to classify patients, documenting signs and symptoms for diagnosis and insurance authorization purposes, and differentiating plaque psoriasis from common mimickers.

Erin Boh, MD, PhD, FAAD, shares insight into clinical manifestations of plaque psoriasis, and panelists emphasize how disease characteristics may be mistaken for signs and symptoms of commonly comorbid diseases.

An expert dermatologist, George Han, MD, PhD, provides a brief overview of the pathogenesis of plaque psoriasis and reviews some common environmental triggers.